+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biosimulation Market Research Report by Product & Service, Delivery Model, End-user, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 249 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 5454874
UP TO OFF until Dec 31st 2022
The Global Biosimulation Market size was estimated at USD 2,461.84 million in 2021, USD 2,874.69 million in 2022, and is projected to grow at a CAGR 16.94% to reach USD 6,297.89 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Biosimulation to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product & Service, the market was studied across Services and Software. The Services is further studied across Contract Services and In-house Services. The Software is further studied across Molecular Modeling and Simulation Software, Pbpk Modeling and Simulation Software, Pk/Pd Modeling and Simulation Software, Toxicity Prediction Software, and Trial Design Software.
  • Based on Delivery Model, the market was studied across Ownership Models and Subscription Models.
  • Based on End-user, the market was studied across Contract Research Organizations, Pharmaceutical And Biotechnology Companies, Regulatory Authorities, and Research Institutes.
  • Based on Application, the market was studied across Drug Development and Drug Discovery. The Drug Development is further studied across Clinical Trials and Preclinical Testing. The Preclinical Testing is further studied across Adme/Tox and Pk/Pd. The Drug Discovery is further studied across Lead Identification and Optimization and Target Identification and Validation.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Biosimulation market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biosimulation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biosimulation Market, including Advanced Chemistry Development, Certara, Chemical Computing Group ULC, Dassault Systèmes, Evidera, Gendata AG, In silico biosciences, INOSIM Software, Insilico Biotechnology AG, LeadInvent Pharma Inc, Nuventra Pharma Sciences, Physiomics Plc, Rosa & Co. LLC., Schrödinger, Inc., and Simulations Plus.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Biosimulation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biosimulation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biosimulation Market?
4. What is the competitive strategic window for opportunities in the Global Biosimulation Market?
5. What are the technology trends and regulatory frameworks in the Global Biosimulation Market?
6. What is the market share of the leading vendors in the Global Biosimulation Market?
7. What modes and strategic moves are considered suitable for entering the Global Biosimulation Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Potential demand attributed to adaptations of biosimulation in various sectors such as biotechnology
5.1.1.2. Growing demand associated with application of biosimulation in clinical trials
5.1.1.3. Rising investments in drug developments and drug testings
5.1.2. Restraints
5.1.2.1. Upscaled prices involved in installations and technique developments for biosimulation
5.1.3. Opportunities
5.1.3.1. Favorable governmental laws and regulations to implement biosimulation
5.1.3.2. Increasing investments in research and development for utilization of biosimulation
5.1.4. Challenges
5.1.4.1. Lack of awareness coupled with scarcity of professionals for research and development
5.2. Cumulative Impact of COVID-19
6. Biosimulation Market, by Product & Service
6.1. Introduction
6.2. Services
6.2.1. Contract Services
6.2.2. In-house Services
6.3. Software
6.3.1. Molecular Modeling and Simulation Software
6.3.2. Pbpk Modeling and Simulation Software
6.3.3. Pk/Pd Modeling and Simulation Software
6.3.4. Toxicity Prediction Software
6.3.5. Trial Design Software
7. Biosimulation Market, by Delivery Model
7.1. Introduction
7.2. Ownership Models
7.3. Subscription Models
8. Biosimulation Market, by End-user
8.1. Introduction
8.2. Contract Research Organizations
8.3. Pharmaceutical And Biotechnology Companies
8.4. Regulatory Authorities
8.5. Research Institutes
9. Biosimulation Market, by Application
9.1. Introduction
9.2. Drug Development
9.2.1. Clinical Trials
9.2.2. Preclinical Testing
9.2.2.1. Adme/Tox
9.2.2.2. Pk/Pd
9.3. Drug Discovery
9.3.1. Lead Identification and Optimization
9.3.2. Target Identification and Validation
10. Americas Biosimulation Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Biosimulation Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Biosimulation Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Advanced Chemistry Development
14.2. Certara
14.3. Chemical Computing Group ULC
14.4. Dassault Systèmes
14.5. Evidera
14.6. Gendata AG
14.7. In silico biosciences
14.8. INOSIM Software
14.9. Insilico Biotechnology AG
14.10. LeadInvent Pharma Inc
14.11. Nuventra Pharma Sciences
14.12. Physiomics Plc
14.13. Rosa & Co. LLC.
14.14. Schrödinger, Inc.
14.15. Simulations Plus
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL BIOSIMULATION MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL BIOSIMULATION MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL BIOSIMULATION MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL BIOSIMULATION MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOSIMULATION MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL BIOSIMULATION MARKET DYNAMICS
FIGURE 8. GLOBAL BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2027
FIGURE 11. GLOBAL BIOSIMULATION MARKET SIZE, BY SERVICES, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL BIOSIMULATION MARKET SIZE, BY SERVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL BIOSIMULATION MARKET SIZE, BY CONTRACT SERVICES, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL BIOSIMULATION MARKET SIZE, BY CONTRACT SERVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL BIOSIMULATION MARKET SIZE, BY IN-HOUSE SERVICES, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL BIOSIMULATION MARKET SIZE, BY IN-HOUSE SERVICES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL BIOSIMULATION MARKET SIZE, BY SOFTWARE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL BIOSIMULATION MARKET SIZE, BY MOLECULAR MODELING AND SIMULATION SOFTWARE, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL BIOSIMULATION MARKET SIZE, BY MOLECULAR MODELING AND SIMULATION SOFTWARE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL BIOSIMULATION MARKET SIZE, BY PBPK MODELING AND SIMULATION SOFTWARE, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL BIOSIMULATION MARKET SIZE, BY PBPK MODELING AND SIMULATION SOFTWARE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL BIOSIMULATION MARKET SIZE, BY PK/PD MODELING AND SIMULATION SOFTWARE, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL BIOSIMULATION MARKET SIZE, BY PK/PD MODELING AND SIMULATION SOFTWARE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL BIOSIMULATION MARKET SIZE, BY TOXICITY PREDICTION SOFTWARE, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL BIOSIMULATION MARKET SIZE, BY TOXICITY PREDICTION SOFTWARE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL BIOSIMULATION MARKET SIZE, BY TRIAL DESIGN SOFTWARE, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL BIOSIMULATION MARKET SIZE, BY TRIAL DESIGN SOFTWARE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2021 VS 2027 (%)
FIGURE 30. GLOBAL BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2021 VS 2027 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2027
FIGURE 32. GLOBAL BIOSIMULATION MARKET SIZE, BY OWNERSHIP MODELS, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL BIOSIMULATION MARKET SIZE, BY OWNERSHIP MODELS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL BIOSIMULATION MARKET SIZE, BY SUBSCRIPTION MODELS, 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL BIOSIMULATION MARKET SIZE, BY SUBSCRIPTION MODELS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL BIOSIMULATION MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 37. GLOBAL BIOSIMULATION MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOSIMULATION MARKET SIZE, BY END-USER, 2027
FIGURE 39. GLOBAL BIOSIMULATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2019-2027 (USD MILLION)
FIGURE 40. GLOBAL BIOSIMULATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 41. GLOBAL BIOSIMULATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2019-2027 (USD MILLION)
FIGURE 42. GLOBAL BIOSIMULATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 43. GLOBAL BIOSIMULATION MARKET SIZE, BY REGULATORY AUTHORITIES, 2019-2027 (USD MILLION)
FIGURE 44. GLOBAL BIOSIMULATION MARKET SIZE, BY REGULATORY AUTHORITIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 45. GLOBAL BIOSIMULATION MARKET SIZE, BY RESEARCH INSTITUTES, 2019-2027 (USD MILLION)
FIGURE 46. GLOBAL BIOSIMULATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 47. GLOBAL BIOSIMULATION MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 48. GLOBAL BIOSIMULATION MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOSIMULATION MARKET SIZE, BY APPLICATION, 2027
FIGURE 50. GLOBAL BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2019-2027 (USD MILLION)
FIGURE 51. GLOBAL BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 52. GLOBAL BIOSIMULATION MARKET SIZE, BY CLINICAL TRIALS, 2019-2027 (USD MILLION)
FIGURE 53. GLOBAL BIOSIMULATION MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 54. GLOBAL BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2019-2027 (USD MILLION)
FIGURE 55. GLOBAL BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 56. GLOBAL BIOSIMULATION MARKET SIZE, BY ADME/TOX, 2019-2027 (USD MILLION)
FIGURE 57. GLOBAL BIOSIMULATION MARKET SIZE, BY ADME/TOX, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 58. GLOBAL BIOSIMULATION MARKET SIZE, BY PK/PD, 2019-2027 (USD MILLION)
FIGURE 59. GLOBAL BIOSIMULATION MARKET SIZE, BY PK/PD, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 60. GLOBAL BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2019-2027 (USD MILLION)
FIGURE 61. GLOBAL BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 62. GLOBAL BIOSIMULATION MARKET SIZE, BY LEAD IDENTIFICATION AND OPTIMIZATION, 2019-2027 (USD MILLION)
FIGURE 63. GLOBAL BIOSIMULATION MARKET SIZE, BY LEAD IDENTIFICATION AND OPTIMIZATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 64. GLOBAL BIOSIMULATION MARKET SIZE, BY TARGET IDENTIFICATION AND VALIDATION, 2019-2027 (USD MILLION)
FIGURE 65. GLOBAL BIOSIMULATION MARKET SIZE, BY TARGET IDENTIFICATION AND VALIDATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 66. AMERICAS BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. AMERICAS BIOSIMULATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 68. AMERICAS BIOSIMULATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 69. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS BIOSIMULATION MARKET SIZE, BY COUNTRY, 2027
FIGURE 70. ARGENTINA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. BRAZIL BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. CANADA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. MEXICO BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. UNITED STATES BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. UNITED STATES BIOSIMULATION MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 76. UNITED STATES BIOSIMULATION MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 77. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BIOSIMULATION MARKET SIZE, BY STATE, 2027
FIGURE 78. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 80. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 81. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY COUNTRY, 2027
FIGURE 82. AUSTRALIA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. CHINA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. INDIA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. INDONESIA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. JAPAN BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. MALAYSIA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 88. PHILIPPINES BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 89. SINGAPORE BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 90. SOUTH KOREA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 91. TAIWAN BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 92. THAILAND BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 93. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 94. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 95. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 96. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY COUNTRY, 2027
FIGURE 97. FRANCE BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 98. GERMANY BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 99. ITALY BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 100. NETHERLANDS BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 101. QATAR BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 102. RUSSIA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 103. SAUDI ARABIA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 104. SOUTH AFRICA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 105. SPAIN BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 106. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 107. UNITED KINGDOM BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 108. GLOBAL BIOSIMULATION MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 109. GLOBAL BIOSIMULATION MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 110. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOSIMULATION MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL BIOSIMULATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL BIOSIMULATION MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL BIOSIMULATION MARKET SIZE, BY SERVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS BIOSIMULATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES BIOSIMULATION MARKET SIZE, BY SERVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL BIOSIMULATION MARKET SIZE, BY CONTRACT SERVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS BIOSIMULATION MARKET SIZE, BY CONTRACT SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES BIOSIMULATION MARKET SIZE, BY CONTRACT SERVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY CONTRACT SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY CONTRACT SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL BIOSIMULATION MARKET SIZE, BY IN-HOUSE SERVICES, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS BIOSIMULATION MARKET SIZE, BY IN-HOUSE SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES BIOSIMULATION MARKET SIZE, BY IN-HOUSE SERVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY IN-HOUSE SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY IN-HOUSE SERVICES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL BIOSIMULATION MARKET SIZE, BY SOFTWARE, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS BIOSIMULATION MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES BIOSIMULATION MARKET SIZE, BY SOFTWARE, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL BIOSIMULATION MARKET SIZE, BY MOLECULAR MODELING AND SIMULATION SOFTWARE, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS BIOSIMULATION MARKET SIZE, BY MOLECULAR MODELING AND SIMULATION SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES BIOSIMULATION MARKET SIZE, BY MOLECULAR MODELING AND SIMULATION SOFTWARE, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY MOLECULAR MODELING AND SIMULATION SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY MOLECULAR MODELING AND SIMULATION SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL BIOSIMULATION MARKET SIZE, BY PBPK MODELING AND SIMULATION SOFTWARE, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS BIOSIMULATION MARKET SIZE, BY PBPK MODELING AND SIMULATION SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES BIOSIMULATION MARKET SIZE, BY PBPK MODELING AND SIMULATION SOFTWARE, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY PBPK MODELING AND SIMULATION SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY PBPK MODELING AND SIMULATION SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL BIOSIMULATION MARKET SIZE, BY PK/PD MODELING AND SIMULATION SOFTWARE, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS BIOSIMULATION MARKET SIZE, BY PK/PD MODELING AND SIMULATION SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES BIOSIMULATION MARKET SIZE, BY PK/PD MODELING AND SIMULATION SOFTWARE, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY PK/PD MODELING AND SIMULATION SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY PK/PD MODELING AND SIMULATION SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL BIOSIMULATION MARKET SIZE, BY TOXICITY PREDICTION SOFTWARE, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS BIOSIMULATION MARKET SIZE, BY TOXICITY PREDICTION SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES BIOSIMULATION MARKET SIZE, BY TOXICITY PREDICTION SOFTWARE, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY TOXICITY PREDICTION SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY TOXICITY PREDICTION SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL BIOSIMULATION MARKET SIZE, BY TRIAL DESIGN SOFTWARE, BY REGION, 2019-2027 (USD MILLION)
TABLE 47. AMERICAS BIOSIMULATION MARKET SIZE, BY TRIAL DESIGN SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. UNITED STATES BIOSIMULATION MARKET SIZE, BY TRIAL DESIGN SOFTWARE, BY STATE, 2019-2027 (USD MILLION)
TABLE 49. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY TRIAL DESIGN SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY TRIAL DESIGN SOFTWARE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. GLOBAL BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 52. GLOBAL BIOSIMULATION MARKET SIZE, BY OWNERSHIP MODELS, BY REGION, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS BIOSIMULATION MARKET SIZE, BY OWNERSHIP MODELS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. UNITED STATES BIOSIMULATION MARKET SIZE, BY OWNERSHIP MODELS, BY STATE, 2019-2027 (USD MILLION)
TABLE 55. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY OWNERSHIP MODELS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY OWNERSHIP MODELS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. GLOBAL BIOSIMULATION MARKET SIZE, BY SUBSCRIPTION MODELS, BY REGION, 2019-2027 (USD MILLION)
TABLE 58. AMERICAS BIOSIMULATION MARKET SIZE, BY SUBSCRIPTION MODELS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. UNITED STATES BIOSIMULATION MARKET SIZE, BY SUBSCRIPTION MODELS, BY STATE, 2019-2027 (USD MILLION)
TABLE 60. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY SUBSCRIPTION MODELS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY SUBSCRIPTION MODELS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. GLOBAL BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 63. GLOBAL BIOSIMULATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 64. AMERICAS BIOSIMULATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. UNITED STATES BIOSIMULATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 66. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. GLOBAL BIOSIMULATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 69. AMERICAS BIOSIMULATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. UNITED STATES BIOSIMULATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 71. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 73. GLOBAL BIOSIMULATION MARKET SIZE, BY REGULATORY AUTHORITIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 74. AMERICAS BIOSIMULATION MARKET SIZE, BY REGULATORY AUTHORITIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. UNITED STATES BIOSIMULATION MARKET SIZE, BY REGULATORY AUTHORITIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 76. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY REGULATORY AUTHORITIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY REGULATORY AUTHORITIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. GLOBAL BIOSIMULATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2019-2027 (USD MILLION)
TABLE 79. AMERICAS BIOSIMULATION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. UNITED STATES BIOSIMULATION MARKET SIZE, BY RESEARCH INSTITUTES, BY STATE, 2019-2027 (USD MILLION)
TABLE 81. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. GLOBAL BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 84. GLOBAL BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2019-2027 (USD MILLION)
TABLE 85. AMERICAS BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. UNITED STATES BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 87. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 89. GLOBAL BIOSIMULATION MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 90. AMERICAS BIOSIMULATION MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 91. UNITED STATES BIOSIMULATION MARKET SIZE, BY CLINICAL TRIALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 92. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 94. GLOBAL BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, BY REGION, 2019-2027 (USD MILLION)
TABLE 95. AMERICAS BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 96. UNITED STATES BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, BY STATE, 2019-2027 (USD MILLION)
TABLE 97. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 99. GLOBAL BIOSIMULATION MARKET SIZE, BY ADME/TOX, BY REGION, 2019-2027 (USD MILLION)
TABLE 100. AMERICAS BIOSIMULATION MARKET SIZE, BY ADME/TOX, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 101. UNITED STATES BIOSIMULATION MARKET SIZE, BY ADME/TOX, BY STATE, 2019-2027 (USD MILLION)
TABLE 102. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY ADME/TOX, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY ADME/TOX, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 104. GLOBAL BIOSIMULATION MARKET SIZE, BY PK/PD, BY REGION, 2019-2027 (USD MILLION)
TABLE 105. AMERICAS BIOSIMULATION MARKET SIZE, BY PK/PD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 106. UNITED STATES BIOSIMULATION MARKET SIZE, BY PK/PD, BY STATE, 2019-2027 (USD MILLION)
TABLE 107. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY PK/PD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY PK/PD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 109. GLOBAL BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2019-2027 (USD MILLION)
TABLE 110. AMERICAS BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 111. UNITED STATES BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, BY STATE, 2019-2027 (USD MILLION)
TABLE 112. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 114. GLOBAL BIOSIMULATION MARKET SIZE, BY LEAD IDENTIFICATION AND OPTIMIZATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 115. AMERICAS BIOSIMULATION MARKET SIZE, BY LEAD IDENTIFICATION AND OPTIMIZATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 116. UNITED STATES BIOSIMULATION MARKET SIZE, BY LEAD IDENTIFICATION AND OPTIMIZATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 117. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY LEAD IDENTIFICATION AND OPTIMIZATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY LEAD IDENTIFICATION AND OPTIMIZATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 119. GLOBAL BIOSIMULATION MARKET SIZE, BY TARGET IDENTIFICATION AND VALIDATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 120. AMERICAS BIOSIMULATION MARKET SIZE, BY TARGET IDENTIFICATION AND VALIDATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 121. UNITED STATES BIOSIMULATION MARKET SIZE, BY TARGET IDENTIFICATION AND VALIDATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 122. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY TARGET IDENTIFICATION AND VALIDATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY TARGET IDENTIFICATION AND VALIDATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 124. AMERICAS BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 125. AMERICAS BIOSIMULATION MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 126. AMERICAS BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 127. AMERICAS BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 128. AMERICAS BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 129. AMERICAS BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 130. ARGENTINA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 131. ARGENTINA BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 132. ARGENTINA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 133. ARGENTINA BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 134. ARGENTINA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 135. BRAZIL BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 136. BRAZIL BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 137. BRAZIL BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 138. BRAZIL BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 139. BRAZIL BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 140. CANADA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 141. CANADA BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 142. CANADA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 143. CANADA BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 144. CANADA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 145. MEXICO BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 146. MEXICO BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 147. MEXICO BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 148. MEXICO BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 149. MEXICO BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 150. UNITED STATES BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 151. UNITED STATES BIOSIMULATION MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 152. UNITED STATES BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 153. UNITED STATES BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 154. UNITED STATES BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 155. UNITED STATES BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 156. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 157. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 158. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 159. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 160. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 161. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 162. AUSTRALIA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 163. AUSTRALIA BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 164. AUSTRALIA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 165. AUSTRALIA BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 166. AUSTRALIA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 167. CHINA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 168. CHINA BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 169. CHINA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 170. CHINA BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 171. CHINA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 172. INDIA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 173. INDIA BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 174. INDIA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 175. INDIA BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 176. INDIA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 177. INDONESIA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 178. INDONESIA BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 179. INDONESIA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 180. INDONESIA BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 181. INDONESIA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 182. JAPAN BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 183. JAPAN BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 184. JAPAN BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 185. JAPAN BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 186. JAPAN BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 187. MALAYSIA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 188. MALAYSIA BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 189. MALAYSIA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 190. MALAYSIA BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 191. MALAYSIA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 192. PHILIPPINES BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 193. PHILIPPINES BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 194. PHILIPPINES BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 195. PHILIPPINES BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 196. PHILIPPINES BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 197. SINGAPORE BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 198. SINGAPORE BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 199. SINGAPORE BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 200. SINGAPORE BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 201. SINGAPORE BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 202. SOUTH KOREA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 203. SOUTH KOREA BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 204. SOUTH KOREA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 205. SOUTH KOREA BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 206. SOUTH KOREA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 207. TAIWAN BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 208. TAIWAN BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 209. TAIWAN BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 210. TAIWAN BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 211. TAIWAN BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 212. THAILAND BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 213. THAILAND BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 214. THAILAND BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 215. THAILAND BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 216. THAILAND BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 223. FRANCE BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 224. FRANCE BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 225. FRANCE BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 226. FRANCE BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 227. FRANCE BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 228. GERMANY BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 229. GERMANY BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 230. GERMANY BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 231. GERMANY BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 232. GERMANY BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 233. ITALY BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 234. ITALY BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 235. ITALY BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 236. ITALY BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 237. ITALY BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 238. NETHERLANDS BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 239. NETHERLANDS BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 240. NETHERLANDS BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 241. NETHERLANDS BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 242. NETHERLANDS BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 243. QATAR BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 244. QATAR BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 245. QATAR BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 246. QATAR BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 247. QATAR BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 248. RUSSIA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 249. RUSSIA BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 250. RUSSIA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 251. RUSSIA BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 252. RUSSIA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 253. SAUDI ARABIA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 254. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 255. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 256. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 257. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 258. SOUTH AFRICA BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 259. SOUTH AFRICA BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 260. SOUTH AFRICA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 261. SOUTH AFRICA BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 262. SOUTH AFRICA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 263. SPAIN BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 264. SPAIN BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 265. SPAIN BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 266. SPAIN BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 267. SPAIN BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 273. UNITED KINGDOM BIOSIMULATION MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 274. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 275. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2019-2027 (USD MILLION)
TABLE 276. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 277. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 278. GLOBAL BIOSIMULATION MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 279. GLOBAL BIOSIMULATION MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 280. GLOBAL BIOSIMULATION MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 281. GLOBAL BIOSIMULATION MARKET RANKING
TABLE 282. GLOBAL BIOSIMULATION MARKET SHARE, BY KEY PLAYER, 2021
TABLE 283. GLOBAL BIOSIMULATION MARKET MERGER & ACQUISITION
TABLE 284. GLOBAL BIOSIMULATION MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 285. GLOBAL BIOSIMULATION MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 286. GLOBAL BIOSIMULATION MARKET INVESTMENT & FUNDING
TABLE 287. GLOBAL BIOSIMULATION MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 288. GLOBAL BIOSIMULATION MARKET: LICENSE & PRICING

Companies Mentioned

  • Advanced Chemistry Development
  • Certara
  • Chemical Computing Group ULC
  • Dassault Systèmes
  • Evidera
  • Gendata AG
  • In silico biosciences
  • INOSIM Software
  • Insilico Biotechnology AG
  • LeadInvent Pharma Inc
  • Nuventra Pharma Sciences
  • Physiomics Plc
  • Rosa & Co. LLC.
  • Schrödinger, Inc.
  • Simulations Plus

Methodology

Loading
LOADING...